New combo attack on liver cancer aims to stop it from returning
NCT ID NCT07352007
Summary
This study is testing if a new treatment approach can better control liver cancer. It will compare two groups: one receives a drug (sintilimab) and targeted radiation before surgery, while the other has surgery right away. The main goal is to see if the pre-surgery treatment lowers the chance of the cancer coming back within three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ShandongShandong Cancer Hospital and Institute
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.